Ho Carole Insider Trading
Get the latest insider transactions of Ho Carole. Ho Carole is Director in NGM BIOPHARMACEUTICALS INC ($NGM) and Chief Medical Officer in Denali Therapeutics Inc. ($DNLI). Discover the current value of Ho Carole shares.
Address: C/O DENALI THERAPEUTICS INC. 151 OYSTER POINT BOULEVARD, SECOND FLOOR SOUTH SAN FRANCISCO 94080CA
Ho Carole is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | Chief Medical Officer | 162,319 | |
| NGM | NGM BIOPHARMACEUTICALS INC | Director | 0 |
Insider Trading Transactions of Ho Carole
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | NGM | NGM BIOPHARMACEUTICALS IN ... | Ho Carole | Director | Option Exercise | 17.24 | 19,619 | 338,232 | 19,619 |
| Mar 31 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 54.62 | 2,822 | 154,126 | 162,319 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 64.54 | 1,327 | 85,646 | 170,906 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 65.74 | 2,871 | 188,725 | 168,035 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 67.07 | 1,173 | 78,670 | 166,862 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 68.01 | 1,320 | 89,772 | 165,542 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 68.87 | 208 | 14,324 | 165,334 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 70.07 | 125 | 8,758 | 165,209 |
| Mar 03 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 71.27 | 68 | 4,846 | 165,141 |
| Feb 16 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 70.17 | 2,756 | 193,377 | 172,633 |
| Feb 16 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 71.49 | 400 | 28,594 | 172,233 |
| Feb 11 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 0.00 | 4,250 | 0 | 169,391 |
| Feb 11 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 74.40 | 1,006 | 74,847 | 168,385 |
| Feb 11 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 75.10 | 364 | 27,337 | 168,021 |
| Feb 11 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 76.00 | 100 | 7,600 | 167,921 |
| Feb 11 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 4,250 | 0 | 8,500 |
| Jan 06 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 30,000 | 0 | 30,000 |
| Jan 06 2021 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 70.86 | 90,000 | 6,377,400 | 90,000 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 22,906 | 120,944 | 189,523 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 40.12 | 22,906 | 918,989 | 166,617 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 30,000 | 158,400 | 196,617 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 40.68 | 10,465 | 425,716 | 186,152 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 41.51 | 19,535 | 810,898 | 166,617 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 13,020 | 68,746 | 44,035 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 9,886 | 52,198 | 68,240 |
| Oct 13 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 30,000 | 158,400 | 38,240 |
| Sep 14 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 31.00 | 3,689 | 114,359 | 165,141 |
| Sep 14 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 31.00 | 3,689 | 114,359 | 165,141 |
| Aug 24 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 0.00 | 5,643 | 0 | 8,465 |
| Aug 24 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 32.88 | 1,954 | 64,248 | 6,511 |
| Aug 24 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 5,643 | 0 | 0 |
| Aug 24 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 0.00 | 5,643 | 0 | 8,465 |
| Aug 24 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 32.88 | 1,954 | 64,248 | 6,511 |
| Aug 24 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 5,643 | 0 | 0 |
| Aug 20 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 20,000 | 0 | 20,000 |
| Jun 09 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Ho Carole | Director | Option Exercise | 20.66 | 39,515 | 816,380 | 39,515 |
| Apr 01 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.48 | 1,428 | 27,817 | 2,822 |
| Feb 12 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 29,874 | 0 | 29,874 |
| Feb 12 2020 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 24.81 | 142,000 | 3,523,020 | 142,000 |
| Dec 23 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.00 | 2,566 | 51,320 | 4,324 |
| Dec 23 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.00 | 860 | 17,200 | 3,464 |
| Dec 23 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.01 | 3,464 | 69,315 | 0 |
| Aug 22 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 0.00 | 5,643 | 0 | 52,518 |
| Aug 22 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.59 | 2,834 | 52,671 | 49,684 |
| Aug 22 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 5,643 | 0 | 5,643 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 2,604 | 13,749 | 6,685 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.93 | 2,604 | 51,898 | 4,081 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 3,907 | 20,629 | 7,988 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.55 | 3,907 | 80,289 | 4,081 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.21 | 9,889 | 199,857 | 81,034 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.88 | 1,100 | 22,968 | 79,934 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 2,604 | 13,749 | 92,565 |
| Jul 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 3,907 | 20,629 | 78,126 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 711 | 3,754 | 711 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.62 | 711 | 13,239 | 0 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 3,906 | 20,624 | 3,906 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.81 | 3,906 | 73,472 | 0 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.78 | 12,883 | 241,943 | 90,923 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 711 | 3,754 | 95,169 |
| Jun 12 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 3,906 | 20,624 | 82,033 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 2,613 | 13,797 | 2,613 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 23.50 | 2,613 | 61,406 | 0 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 23.51 | 3,162 | 74,339 | 110,332 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 2,653 | 14,008 | 2,653 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 22.86 | 2,453 | 56,076 | 200 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 23.58 | 200 | 4,716 | 0 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 22.83 | 3,010 | 68,718 | 107,322 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 23.60 | 200 | 4,720 | 107,122 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 2,546 | 13,443 | 2,546 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 22.17 | 2,546 | 56,445 | 0 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 22.16 | 3,316 | 73,483 | 103,806 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 2,613 | 13,797 | 91,138 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 2,653 | 14,008 | 88,485 |
| May 10 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 2,546 | 13,443 | 85,939 |
| Apr 08 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 26.24 | 8,155 | 213,987 | 114,927 |
| Apr 08 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 27.00 | 1,433 | 38,691 | 113,494 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 5,775 | 30,492 | 5,775 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 23.91 | 5,775 | 138,080 | 0 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 6,135 | 32,393 | 6,135 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 24.51 | 2,800 | 68,628 | 3,335 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 25.15 | 3,335 | 83,875 | 0 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 25.29 | 9,445 | 238,864 | 132,670 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 5.28 | 5,862 | 30,951 | 5,862 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 26.27 | 5,262 | 138,233 | 600 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 26.81 | 600 | 16,086 | 0 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 26.29 | 8,688 | 228,408 | 123,982 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 26.79 | 900 | 24,111 | 123,082 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 5,775 | 30,492 | 105,855 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 6,135 | 32,393 | 99,720 |
| Apr 03 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 5,862 | 30,951 | 93,858 |
| Mar 18 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 25.01 | 500 | 12,505 | 142,115 |
| Mar 18 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 500 | 2,640 | 500 |
| Mar 18 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 25.01 | 500 | 12,505 | 0 |
| Mar 18 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 500 | 2,640 | 111,630 |
| Feb 11 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 17,000 | 0 | 17,000 |
| Feb 11 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 17.99 | 136,000 | 2,446,640 | 136,000 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 5,775 | 30,492 | 5,775 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.64 | 5,775 | 107,646 | 0 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 730 | 3,854 | 730 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 3,139 | 16,574 | 3,869 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.49 | 3,100 | 57,319 | 769 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.11 | 769 | 14,696 | 0 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 7,856 | 41,480 | 7,856 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.83 | 7,856 | 147,928 | 0 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 5,775 | 30,492 | 96,610 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 730 | 3,854 | 95,880 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 3,139 | 16,574 | 137,486 |
| Feb 05 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 7,856 | 41,480 | 129,630 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.43 | 4,875 | 94,721 | 143,515 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.24 | 900 | 18,216 | 142,615 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 5,775 | 30,492 | 8,552 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.90 | 2,777 | 52,485 | 2,777 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Buy | 5.28 | 5,950 | 31,416 | 8,727 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.30 | 1,500 | 28,950 | 7,227 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 20.03 | 4,450 | 89,134 | 2,777 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 5,775 | 30,492 | 108,335 |
| Jan 04 2019 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 5.28 | 5,950 | 31,416 | 102,385 |
| Dec 06 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.43 | 17,100 | 315,170 | 148,790 |
| Dec 06 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.16 | 400 | 7,664 | 148,390 |
| Nov 19 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.07 | 17,500 | 316,157 | 165,890 |
| Oct 03 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 21.72 | 17,500 | 380,100 | 183,390 |
| Sep 06 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 19.05 | 17,500 | 333,375 | 200,890 |
| Aug 31 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 18.04 | 17,500 | 315,700 | 218,390 |
| Aug 22 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 0.00 | 11,286 | 0 | 11,286 |
| Feb 28 2018 | DNLI | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Option Exercise | 22.16 | 180,000 | 3,988,800 | 180,000 |